Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, and Immune Cell Function and Interaction.
Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024)
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
752 | SAFETY AND EFFICACY OF BRENTUXIMAB VEDOTIN IN CHINESE ADULTS WITH CD30+ PERIPHERAL T‐CELL LYMPHOMA: A SUBGROUP ANALYSIS OF BRAVE STUDY
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial
Impact of Vitamin E Supplementation on High‐Density Lipoprotein in Patients With Haptoglobin Genotype–Stratified Diabetes: A Systematic Review of Randomized Controlled Trials
Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphoma
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study
Safety and efficacy of brentuximab vedotin in Chinese adults with CD30+ peripheral T‐cell lymphoma: an interim analysis from a prospective, observational, real‐world study
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Haptoglobin genotypes and risk of vascular complications in a northern Chinese Han population with type 2 diabetes mellitus
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
Advances in targeted therapy for malignant lymphoma
Zanubrutinib monotherapy for patients with relapsed or refractory non-germinal center diffuse large B-cell lymphoma: Results from a phase II, single-arm, multicenter, study.
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial